Researchers used NGS to profile the tumors of metastatic colorectal carcinoma patients enrolled in the CAPRI-GOIM clinical trial.
Infectious disease assays accounted for 64 percent of total assay sales in the quarter.
The company is embarking on a study of up to 2,000 patients to compare its tissue-based targeted sequencing assay with its cell-free DNA test.
The Australian firm regained compliance with a listing rule requiring a minimum $2.5 million in stockholder equity.
MedStar Health, which has 10 hospitals in Maryland and Washington DC, is now part of the Caris Centers of Excellence for Precision Medicine Network.
In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.
Cancer clinical trial patients settle with Anil Potti and Duke University.
A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.
Two Johns Hopkins researchers discuss the need for evidence-based data analysis.